.jpg/:/rs=h:100,cg:true,m/qt=q:95)
carboxamil- the Pancreatic cancer drug of the future today
Transforming biotechnology with cutting-edge innovations.
Revolutionizing the way pancreatic cancer is treated
Carboxamil
Carboxamil is a repurposed FDA approved drug that is non-toxic with no known side effects, meaning no hair loss, no compromised immune system, no infections from using Carboxamil
Mode of Action
Carboxamil binds to receptor GPCR 35 and turns off the cancer cascade. By turning off the cancer cascade NEW tumors cannot form, grow or metastasize allowing for the immune system to destroy and dissolve the tumors that are present
Local target therapy
Carboxamil is delivered directly to the tumor site by a state-or-the-art catheter allowing for 100% of Carboxamil drug concentration to destroy the tumors
Biomarkers
Carcinex Inc has developed the most advanced early detection biomarkers for solid tumors cancers. These biomarkers have 95% selectivity. These biomarkers are not present in normal tissue